I refer to the claims section of the 21 February edition of The Lawyer on page 25.
You report that a woman named Rebecca Shaw has launched proceedings against her doctor and Roche Products in connection with the anti-malarial drug Lariam.
However, Shaw discontinued her claim approximately two years ago. What has happened is that the case, and a number of other discontinued Lariam cases, has been transferred to the Royal Courts of Justice for the purpose of dealing with legal aid costs.
Richard Daniel, director of legal affairs, Roche Products